Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Biomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET) Proceeding/Conference:ESMO (European Society for Medical On) ASIA 2018 | 2018 | ||
Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC) Proceeding/Conference:Annals of Oncology | 2021 | ||
2020 |